Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity
暂无分享,去创建一个
J M Links | H N Wagner | J. Links | A. Gjedde | D. Wong | M. Kuhar | R. Dannals | H. Wagner | K. Douglass | R F Dannals | A Gjedde | M J Kuhar | D F Wong | K H Douglass
[1] A. Gjedde,et al. Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] T Greitz,et al. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[3] Alan A. Wilson,et al. Dopamine and serotonin receptors measured in vivo in Huntington's Disease with C-11 n-methylspiperone PET imaging , 1985 .
[4] D Comar,et al. Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. , 1985, European journal of pharmacology.
[5] C. D. Arnett,et al. Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography , 1985, Journal of neurochemistry.
[6] Dean F. Wong,et al. Imaging Opiate Receptors in the Human Brain by Positron Tomography , 1985, Journal of computer assisted tomography.
[7] G. di Chiro,et al. Atlas of Dopamine Receptor Images (PET) of the Human Brain , 1985, Journal of computer assisted tomography.
[8] J. Links,et al. Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report. , 1985, Psychopharmacology bulletin.
[9] M. Folstein,et al. EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.
[10] P Riederer,et al. Bimodal distribution of dopamine receptor densities in brains of schizophrenics. , 1984, Science.
[11] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[12] J. Links,et al. An anatomically realistic brain phantom for quantification with positron tomography , 1984 .
[13] J. Links,et al. Imaging dopamine receptors in the human brain by positron tomography. , 1984, Science.
[14] M. Mintun,et al. Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. , 1983, Life sciences.
[15] Jonathan M. Links,et al. Imaging dopamine receptors in the human brain by positron tomography , 1983 .
[16] J C Mazziotta,et al. Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.
[17] P. Seeman. Brain dopamine receptors. , 1980, Pharmacological reviews.
[18] M. Raichle,et al. Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors , 1980, Brain Research.
[19] J. Leysen,et al. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.
[20] M. Kuhar,et al. Dopamine receptor binding in vivo: the feasibility of autoradiographic studies. , 1978, Life sciences.